Catyalyst Pharmaceutical (CPRX) Posts Q3 Loss of 6c/Share
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.38 --0%
Revenue Growth %: +5.9%
Financial Fact:
Research and development: 2.49M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +5.9%
Financial Fact:
Research and development: 2.49M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Catyalyst Pharmaceutical (NASDAQ: CPRX) reported Q3 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05).
For earnings history and earnings-related data on Catyalyst Pharmaceutical (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- NVE Corporation names new CEO and expands board to seven members
- Hermès can regain momentum despite China weakness, Jefferies says
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
